<DOC>
	<DOCNO>NCT01015027</DOCNO>
	<brief_summary>This study test safety tolerability ( body reacts drug ) REGN668 placebo ( inactive substance contains medicine ) healthy subject .</brief_summary>
	<brief_title>Ascending Dose Study Safety Tolerability REGN668 ( SAR231893 ) Normal Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Male female 18 65 year age . 2 . Weight &gt; 50 kg &lt; 120 kg . 3 . For woman childbearing potential , negative serum pregnancy test screen visit ( visit 1 ) negative urine pregnancy test day 1 . 4 . Willingness refrain consumption alcohol 24 hour prior study visit . 5 . For men woman childbearing potential , willingness utilize adequate contraception become pregnant ( partner [ ] become pregnant ) full duration study . 6 . Willing , commit , able return ALL clinic visit complete studyrelated procedure . 7 . Able read , understand willing sign inform consent form . 1 . Onset new exercise routine major change previous exercise routine within 4 week prior screen visit . 2 . Pregnant breastfeed woman . 3 . Significant concomitant illness history significant illness cardiac , renal , neurological , endocrinological , metabolic lymphatic disease , illness condition would adversely affect subject 's participation study . 4 . Hospitalization reason within 60 day screen ( visit 1 ) . 5 . Known history Human Immunodeficiency Virus ( HIV ) , Hepatitis B Hepatitis C , and/or positive Hepatitis B surface antigen ( HBsAg ) , positive Hepatitis C antibody ( HCV ) . 6 . Previous exposure therapeutic investigational biological agent . result . 7 . History alcohol substance abuse within previous 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>